Our Story
SomnoMed is a publicly traded company (ASX:SOM) founded in 2004 in Sydney, Australia. The North American office, located in Plano, Texas was opened in 2006; introducing their leading device technology to patients in America. To date there have been over 480,000 patients around the world who have been treated with SomnoDent therapy.
As the global leader in COAT (Continuous Open Airway Therapy) SomnoMed provides clinically proven diagnostic and treatment options for sleep-related breathing disorders such as obstructive sleep apnea (OSA) and sleep bruxism.
SomnoMed is a public company providing diagnostic and treatment solutions for Sleep-related Breathing Disorders including obstructive sleep apnea, snoring and bruxism. SomnoMed was commercialized on the basis of extensive clinical research. Supporting independent clinical research, continuous innovation and instituting medical manufacturing standards has resulted in SomnoDent® becoming the state-of-the-art and clinically proven medical oral appliance therapy for obstructive sleep apnea. SomnoDent® is the most comfortable and effective design and treatment solution for over 480,000 patients in 28 countries.
At SomnoMed, we keep the patient at the center of our focus and know that successful treatment is much more than just the device. With our history of innovation, commitment to connecting physicians and dentists, SomnoMed provides patients with the products and services they need to return to enjoying their lives.
For additional information, visit SomnoMed at http://www.somnomed.com